| Product Code: ETC7922079 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Latvia`s import shipments of specialty injectable generics continued to see steady growth, with key exporting countries being Lithuania, Netherlands, Switzerland, Poland, and Germany. Despite the presence of multiple suppliers, the market remained relatively unconcentrated with a low Herfindahl-Hirschman Index (HHI). The compound annual growth rate (CAGR) from 2020 to 2024 stood at a robust 8.6%, indicating a favorable market trajectory. Additionally, the growth rate from 2023 to 2024 was recorded at 7.03%, highlighting sustained momentum in the import of specialty injectable generics into Latvia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Specialty Injectable Generics Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Specialty Injectable Generics Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Specialty Injectable Generics Market - Industry Life Cycle |
3.4 Latvia Specialty Injectable Generics Market - Porter's Five Forces |
3.5 Latvia Specialty Injectable Generics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Latvia Specialty Injectable Generics Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Latvia Specialty Injectable Generics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Latvia Specialty Injectable Generics Market Trends |
6 Latvia Specialty Injectable Generics Market, By Types |
6.1 Latvia Specialty Injectable Generics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Specialty Injectable Generics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Latvia Specialty Injectable Generics Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.4 Latvia Specialty Injectable Generics Market Revenues & Volume, By Biologics, 2021- 2031F |
6.2 Latvia Specialty Injectable Generics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Latvia Specialty Injectable Generics Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.3 Latvia Specialty Injectable Generics Market Revenues & Volume, By Cardiovascular, 2021- 2031F |
6.2.4 Latvia Specialty Injectable Generics Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.5 Latvia Specialty Injectable Generics Market Revenues & Volume, By Central Nervous Systems, 2021- 2031F |
6.2.6 Latvia Specialty Injectable Generics Market Revenues & Volume, By Autoimmune Disorders, 2021- 2031F |
6.2.7 Latvia Specialty Injectable Generics Market Revenues & Volume, By Others, 2021- 2031F |
7 Latvia Specialty Injectable Generics Market Import-Export Trade Statistics |
7.1 Latvia Specialty Injectable Generics Market Export to Major Countries |
7.2 Latvia Specialty Injectable Generics Market Imports from Major Countries |
8 Latvia Specialty Injectable Generics Market Key Performance Indicators |
9 Latvia Specialty Injectable Generics Market - Opportunity Assessment |
9.1 Latvia Specialty Injectable Generics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Latvia Specialty Injectable Generics Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Latvia Specialty Injectable Generics Market - Competitive Landscape |
10.1 Latvia Specialty Injectable Generics Market Revenue Share, By Companies, 2024 |
10.2 Latvia Specialty Injectable Generics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |